Insiders who reported open-market trades in the last 12 months at the companies Carl Dambkowski files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Carl Dambkowski is a corporate insider, tracked as Chief Medical Officer of Apogee Therapeutics, Inc. (APGE). InsiderAlpha holds 25 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Carl Dambkowski submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Carl Dambkowski been buying or selling stock?
Recorded transactions: 0 open-market purchases and 41 open-market sales ($19.30M) across all tracked filings.
Carl Dambkowski is Chief Medical Officer of Apogee Therapeutics, Inc. (APGE). 25 SEC Form 4 filings on record going back to 2024, most recently on 3 September 2026. Most recent open-market trade: sold $738K of APGE on 8 August 2026. Lifetime open-market sales: $19.30M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Carl Dambkowski.
InsiderAlpha's records for Carl Dambkowski go back to 2024: 25 primary Form 4 filings, an average of 8.3 per year. 61 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
